RespireRx Pharmaceuticals Inc. filed its 10-K on Apr 17, 2023 for the period ending Dec 31, 2022. In this report its auditor, Haskell & White LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.00094 USD | -2.08% | -10.00% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 744K | |
+7.63% | 111B | |
+11.19% | 106B | |
-12.34% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-9.05% | 16.81B | |
+38.39% | 12.54B | |
-24.53% | 8.09B |
- Stock Market
- Equities
- RSPI Stock
- News RespireRx Pharmaceuticals Inc.
- RespireRx Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt